Terms: = Germ cell tumor AND PBRM1, BAF180, 55193, PB1, MGC156156, MGC156155
21 results:
1. The immune response-related genomic alterations in patients with malignant melanoma.
Li L; Xiang T; Li X
Medicine (Baltimore); 2024 Apr; 103(17):e37966. PubMed ID: 38669390
[TBL] [Abstract] [Full Text] [Related]
2. Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas.
Mota M; Sweha SR; Pun M; Natarajan SK; Ding Y; Chung C; Hawes D; Yang F; Judkins AR; Samajdar S; Cao X; Xiao L; Parolia A; Chinnaiyan AM; Venneti S
Proc Natl Acad Sci U S A; 2023 May; 120(18):e2221175120. PubMed ID: 37094128
[TBL] [Abstract] [Full Text] [Related]
3. The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers.
Passeri T; Gutman T; Hamza A; Adle-Biassette H; Girard E; Beaurepere R; Tariq Z; Mariani O; Dahmani A; Bourneix C; Abbritti R; Driouch K; Bohec M; Servant N; Baulande S; Decaudin D; Guichard JP; Calugaru V; Feuvret L; Guinebretière JM; Champion L; Bièche I; Froelich S; Mammar H; Masliah-Planchon J
J Neurosurg; 2023 Nov; 139(5):1270-1280. PubMed ID: 37029667
[TBL] [Abstract] [Full Text] [Related]
4. pbrm1 and BAP1: novel genetic mutations in malignant transformation of craniopharyngioma-a case report.
Tamura M; Yokogami K; Watanabe T; Kawano T; Muta J; Yamashita S; Oguri N; Sato Y; Takeshima H
Brain Tumor Pathol; 2023 Jan; 40(1):40-44. PubMed ID: 36369599
[TBL] [Abstract] [Full Text] [Related]
5. Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes.
Bai J; Shi J; Zhang Y; Li C; Xiong Y; Koka H; Wang D; Zhang T; Song L; Luo W; Zhu B; Hicks B; Hutchinson A; Kirk E; Troester MA; Li M; Shen Y; Ma T; Wang J; Liu X; Wang S; Gui S; McMaster ML; Chanock SJ; Parry DM; Goldstein AM; Yang XR
Clin Cancer Res; 2023 Jan; 29(1):261-270. PubMed ID: 36260525
[TBL] [Abstract] [Full Text] [Related]
6. Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival.
Bai J; Shi J; Li C; Wang S; Zhang T; Hua X; Zhu B; Koka H; Wu HH; Song L; Wang D; Wang M; Zhou W; Ballew BJ; Zhu B; Hicks B; Mirabello L; Parry DM; Zhai Y; Li M; Du J; Wang J; Zhang S; Liu Q; Zhao P; Gui S; Goldstein AM; Zhang Y; Yang XR
Nat Commun; 2021 Feb; 12(1):757. PubMed ID: 33536423
[TBL] [Abstract] [Full Text] [Related]
7. ARID2 Deficiency Correlates with the Response to Immune Checkpoint Blockade in Melanoma.
Fukumoto T; Lin J; Fatkhutdinov N; Liu P; Somasundaram R; Herlyn M; Zhang R; Nishigori C
J Invest Dermatol; 2021 Jun; 141(6):1564-1572.e4. PubMed ID: 33333124
[TBL] [Abstract] [Full Text] [Related]
8. ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.
Russo R; Russo V; Cecere F; Valletta M; Gentile MT; Colucci-D'Amato L; Angelini C; Riccio A; Pedone PV; Chambery A; Baglivo I
Int J Biol Macromol; 2021 Jan; 168():67-76. PubMed ID: 33301849
[TBL] [Abstract] [Full Text] [Related]
9. Multi-omic analysis reveals significantly mutated genes and DDX3X as a sex-specific tumor suppressor in cutaneous melanoma.
Alkallas R; Lajoie M; Moldoveanu D; Hoang KV; Lefrançois P; Lingrand M; Ahanfeshar-Adams M; Watters K; Spatz A; Zippin JH; Najafabadi HS; Watson IR
Nat Cancer; 2020 Jun; 1(6):635-652. PubMed ID: 35121978
[TBL] [Abstract] [Full Text] [Related]
10. Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology.
Cros J; Théou-Anton N; Gounant V; Nicolle R; Reyes C; Humez S; Hescot S; Thomas de Montpréville V; Guyétant S; Scoazec JY; Guyard A; de Mestier L; Brosseau S; Mordant P; Castier Y; Gentien D; Ruszniewski P; Zalcman G; Couvelard A; Cazes A
Neuroendocrinology; 2021; 111(1-2):158-169. PubMed ID: 32015233
[TBL] [Abstract] [Full Text] [Related]
11. [Pathological and molecular features of malignancies underlined by BAF complexes inactivation].
Le Quang M; Ranchère-Vince D; Le Loarer F
Ann Pathol; 2019 Dec; 39(6):399-413. PubMed ID: 31255411
[TBL] [Abstract] [Full Text] [Related]
12. Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma.
Bellini A; Bessoltane-Bentahar N; Bhalshankar J; Clement N; Raynal V; Baulande S; Bernard V; Danzon A; Chicard M; Colmet-Daage L; Pierron G; Le Roux L; Planchon JM; Combaret V; Lapouble E; Corradini N; Thebaud E; Gambart M; Valteau-Couanet D; Michon J; Louis-Brennetot C; Janoueix-Lerosey I; Defachelles AS; Bourdeaut F; Delattre O; Schleiermacher G
Int J Cancer; 2019 Nov; 145(10):2781-2791. PubMed ID: 31018240
[TBL] [Abstract] [Full Text] [Related]
13. A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.
Pan D; Kobayashi A; Jiang P; Ferrari de Andrade L; Tay RE; Luoma AM; Tsoucas D; Qiu X; Lim K; Rao P; Long HW; Yuan GC; Doench J; Brown M; Liu XS; Wucherpfennig KW
Science; 2018 Feb; 359(6377):770-775. PubMed ID: 29301958
[TBL] [Abstract] [Full Text] [Related]
14. Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer.
Wang XY; Wang Z; Huang JB; Ren XD; Ye D; Zhu WW; Qin LX
Tumour Biol; 2017 Jun; 39(6):1010428317699111. PubMed ID: 28618948
[TBL] [Abstract] [Full Text] [Related]
15. Genomic aberrations frequently alter chromatin regulatory genes in chordoma.
Wang L; Zehir A; Nafa K; Zhou N; Berger MF; Casanova J; Sadowska J; Lu C; Allis CD; Gounder M; Chandhanayingyong C; Ladanyi M; Boland PJ; Hameed M
Genes Chromosomes Cancer; 2016 Jul; 55(7):591-600. PubMed ID: 27072194
[TBL] [Abstract] [Full Text] [Related]
16. BAP1, pbrm1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies.
Piva F; Santoni M; Matrana MR; Satti S; Giulietti M; Occhipinti G; Massari F; Cheng L; Lopez-Beltran A; Scarpelli M; Principato G; Cascinu S; Montironi R
Expert Rev Mol Diagn; 2015; 15(9):1201-10. PubMed ID: 26166446
[TBL] [Abstract] [Full Text] [Related]
17. SWI/SNF chromatin remodeling complexes and cancer.
Biegel JA; Busse TM; Weissman BE
Am J Med Genet C Semin Med Genet; 2014 Sep; 166C(3):350-66. PubMed ID: 25169151
[TBL] [Abstract] [Full Text] [Related]
18. Biallelic germline and somatic mutations in malignant mesothelioma: multiple mutations in transcription regulators including mSWI/SNF genes.
Yoshikawa Y; Sato A; Tsujimura T; Otsuki T; Fukuoka K; Hasegawa S; Nakano T; Hashimoto-Tamaoki T
Int J Cancer; 2015 Feb; 136(3):560-71. PubMed ID: 24916674
[TBL] [Abstract] [Full Text] [Related]
19. BRG1 promotes survival of UV-irradiated melanoma cells by cooperating with MITF to activate the melanoma inhibitor of apoptosis gene.
Saladi SV; Wong PG; Trivedi AR; Marathe HG; Keenen B; Aras S; Liew ZQ; Setaluri V; de la Serna IL
Pigment Cell Melanoma Res; 2013 May; 26(3):377-91. PubMed ID: 23480510
[TBL] [Abstract] [Full Text] [Related]
20. [Chromatin remodeling defects and cancer: the SWI/SNF example].
Bourdeaut F; Bièche I
Bull Cancer; 2012 Dec; 99(12):1133-40. PubMed ID: 23222069
[TBL] [Abstract] [Full Text] [Related]
[Next]
